Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04844541 · ClinicalTrials.gov registry record
Prophylaxis and Treatment of COVID-19
A clinical trial of COVID-19 and Acute Respiratory Infection, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- Completed
- Registry status
- 450
- Enrollment target
- 3
- Study locations
NCT04844541: Completed study of COVID-19 and Acute Respiratory Infection, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
NCT04844541 is a study of COVID-19 and Acute Respiratory Infection that has completed, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 450 participants, below the 38,463-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04844541, a study of COVID-19 and Acute Respiratory Infection, has completed, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- COMPLETED
- Registry status
- 450 participants
- Enrollment target
- 3
- Study locations
Study Summary
An observation study evaluating physiologic responses and host biomarker expression patterns in early SARS-CoV-2 and acute respiratory infections (ARI) and among their close contacts.
Primary Outcome
Describe the clinical characteristics of ILI and SARS-CoV-2 in the target populations
Conditions Studied
Study Locations (3)
Maryland
- Johns Hopkins University - Baltimore
North Carolina
- Duke Global Health Institute - Durham
Other
- Royal Thai Army Clinical Research Center (RTA CRC)/Royal Thai Army-Armed Forces Research Institute of Medical Sciences (RTA-AFRIMS)/Phramongkutklao Hospital - Bangkok
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2021-06-11 |
| Est. Completion | 2024-02-21 |
What the finished NCT04844541 record still lists
NCT04844541 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 38,463-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 0 interventions.
NCT04844541 reports a single indexed study location in Maryland, North Carolina, Other.
Frequently Asked Questions
What is clinical trial NCT04844541 about?
NCT04844541 is a clinical study titled "Prophylaxis and Treatment of COVID-19". An observation study evaluating physiologic responses and host biomarker expression patterns in early SARS-CoV-2 and acute respiratory infections (ARI) and among their close contacts.
What is the current status of trial NCT04844541?
This trial is currently completed. The enrollment target is 450 participants. The study started on 2021-06-11. Estimated completion is 2024-02-21.
What conditions does trial NCT04844541 study?
This clinical trial studies the following conditions: COVID-19, Acute Respiratory Infection.
Who is sponsoring clinical trial NCT04844541?
This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04844541 being conducted?
This trial has 3 study locations across Maryland, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04844541's enrollment target sits among peer trials
450 118th of 298 higher than 181 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI